Saturday, May 06, 2023 10:38:41 AM
Last few wks it has been breaking out.
$5 break next. More Partners want in, on top of Ono.
Hawk
Recent CUE News
- Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 02:01:00 PM
- Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights • GlobeNewswire Inc. • 04/08/2024 08:05:00 PM
- Cue Biopharma to Host Business Update Call and Webcast • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:00:06 PM
- Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium • GlobeNewswire Inc. • 02/29/2024 03:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:00:07 PM
- Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:02:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:01:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:00:53 PM
- Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit • GlobeNewswire Inc. • 11/22/2023 01:00:00 PM
- Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 11/09/2023 09:05:00 PM
- Cue Biopharma to Present at Three Upcoming Investor Healthcare Conferences in November • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/03/2023 08:15:34 PM
- Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023 • GlobeNewswire Inc. • 11/03/2023 04:00:00 PM
- Cue Biopharma to Host Business Update Call and Webcast • GlobeNewswire Inc. • 11/02/2023 12:00:00 PM
- Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting • GlobeNewswire Inc. • 09/27/2023 01:05:00 PM
- Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA® • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 08:01:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 08:08:25 PM
- Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 08/09/2023 08:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:04:25 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM